RAG MUTATIONS IN SEVERE COMBINED IMMUNODEFICIENCY AND OMENN'S SYNDROME - 04/09/11
Résumé |
In vertebrates, the adoptive immune system recognizes and responds to many foreign antigens by way of the antigen-specific immunoglobulin/B-cell receptor (Ig/BCR) or T-cell receptor (TCR) molecules expressed on the cell surface of B and T lymphocytes, respectively. The Ig receptor of B cells binds to soluble antigens, whereas the TCR recognizes peptide antigens presented by human leukocyte antigen (HLA) molecules.
BCR and TCR genes are generated through the lymphocyte-specific V(D)J recombination process. Lymphocyte-specific and ubiquitous DNA repair proteins involved in this process have been highly conserved throughout evolution. Naturally occurring mutations in the two lymphocyte-specific V(D)J recombination machinery components, recombinase-activating gene 1 and 2 (RAG1 and RAG2), lead to primary immunodeficiencies, indicating the crucial need for the integrity of V(D)J recombination for lymphoid development. A complete RAG1 or RAG2 deficiency causes severe combined immunodeficiency without B and T cells (B−T− severe combined immunodeficiencies [SCID]). In contrast, partial RAG defects result in Omenn's syndrome, an immune deficiency with autoreactive manifestations caused by a residual, oligoclonal lymphocyte repertoire.
Le texte complet de cet article est disponible en PDF.Plan
| Address reprint requests to Klaus Schwarz, MD, Department of Transfusion Medicine, University of Ulm, Helmholtzstrasse 10, D-89081 Ulm, Germany, e-mail: klaus.schwarz@medizin.uni-ulm.de This work was supported by Grant IZKF CO5 from the Bundesministerium für Bildung und Forschung (KS), and the Telethon Grant E.0917 (AV). |
Vol 20 - N° 1
P. 129-142 - février 2000 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
